Price T Rowe Associates Inc Novo Nordisk A S Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Price T Rowe Associates Inc holds 9,583,435 shares of NVO stock, worth $991 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
9,583,435
Previous 9,503,764
0.84%
Holding current value
$991 Million
Previous $1.36 Billion
15.88%
% of portfolio
0.13%
Previous 0.16%
Shares
8 transactions
Others Institutions Holding NVO
# of Institutions
1,957Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$2.09 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.49 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.48 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.38 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.26 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $233B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...